![]() |
市场调查报告书
商品编码
1920926
2025-2029年癌症治疗技术领域的成长机会Growth Opportunities in Cancer Treatment Technologies, 2025-2029 |
||||||
放射线治疗和非放射线治疗推动癌症治疗的变革性发展
癌症治疗技术在透过放射线治疗和非放射线治疗有效清除癌性肿瘤方面发挥着至关重要的作用。这些治疗方法提供高度局部、微创/非侵入性和个人化的治疗方案,有助于有效清除肿瘤。
全球癌症病例日益增多(主要原因是人们对癌症的认识不断提高,以及能够更早诊断的解决方案的出现),这正在加速这些技术的大规模应用。
医疗机构选择这些治疗方法是因为它们能够在有效切除肿瘤的同时保护健康组织,从而改善患者的治疗效果。
Frost & Sullivan的这项研究将癌症治疗技术分为「放射线治疗」和「非放射线治疗」。放射线治疗透过电离能破坏癌细胞的DNA来发挥作用,而非放射线治疗则无需电离辐射即可杀死癌细胞。放射线治疗包括生物导引放射线治疗、近距离放射、自适应放射线治疗、电子近距离放射疗法和表浅放射线治疗。非放射线治疗包括组织溶解疗法(聚焦超音波)、微波消融、水磨术、水热蒸气疗法和用于肿瘤治疗的电磁场疗法。
Radiation and Non-radiation Therapies to Drive Transformational Growth in Cancer Management
Cancer treatment technologies are playing an instrumental role in the effective removal of cancerous tumors through radiation and non-radiation therapies. These therapies offer highly localized, minimally invasive/non-invasive, and personalized treatment options that support effective tumor removal.
The growing burden of cancer cases globally-primarily driven by increased awareness about the condition and the availability of solutions enabling early diagnosis-is accelerating large-scale adoption of these technologies.
Healthcare providers are opting for these therapies because they facilitate effective tumor removal while sparing healthy tissues, thereby improving patient outcomes.
This Frost & Sullivan research study categorizes cancer treatment technologies into radiation therapies, which work by delivering ionizing energy to damage the DNA of cancer cells, and non-radiation therapies, which kill cancer cells without ionizing radiation. Radiation therapy includes biology-guided radiotherapy, brachytherapy, adaptive radiation therapy, electronic brachytherapy, and superficial radiation therapy. Non-radiation therapy includes histotripsy (focused ultrasound), microwave ablation, aquablation, thermal water vapor therapy, and tumor treating fields.